Introduction
Increasing resistance to current antimicrobials is one of the most pressing issues impacting society. Resistant infections are responsible for high rates of morbidity and mortality, causing significant suffering to patients, their family and carers. As resistance to antimicrobials increases so too does the possibility of an age were procedures such as joint replacements, caesarean sections, chemotherapy, implants and transplant surgery are not possible and simple infections kill. Medical devices have an increasingly important role in patient care. An estimated 5 million medical devices, for example catheters and hip replacements, are implanted each year in the United States [1] . This is due to an increasingly elderly population within modern society and a greater demand for technologies to replace the normal physiological functions of the human body.. The medical device provides an optimal surface for the formation of microbial biofilm. This protective biofilm matrix results in an infection 10-1000 times more resistant to standard chemotherapy often resulting in failure of both device and antimicrobial therapy, leading to removal of the implant. As concerns regarding resistance increase there is an urgent need for new antimicrobials that are active against an increasing spectrum of pathogens resistant to commonly used therapeutic regimens.
One potential source of novel antimicrobials may be in nature itself with a recent increase in focus on traditional therapies to aid chronic and acute disease states. Included in these range of remedies are essential oils; traditional remedies for relief of the common cold, acute sinusitis and respiratory tract infections. Research by Ioannou demonstrated oils from cinnamon bark to be amongst the most microbicidal naturally occurring compounds [2] .
Antimicrobial peptides serve as an alternative source of therapeutics. A diverse reservoir of peptides exist in nature with potent activity shown against a broad range of microorganisms via multiple modes of action [3] . Further research has allowed the identification of a structural pharmacophore (two units of hydrophobic bulk and two of charge) that acts as the minimum motif to provide antimicrobial action [4] . Recently, Bisht et al produced a series of amino terminal modified peptides containing two ornithine (providing charge) and two tryptophan residues (providing bulk) with significantly reduced minimum inhibitory concentration (MIC) values for amino terminal peptides in comparison to C-terminal carboxylic acids [5] . This original research paper outlines the activity of a range of ultrashort cinnamic acid peptide derivatives against a variety of clinically relevant biofilm forms of pathogens implicated in medical device related infection. Their cytotoxicity is compared via tissue culture (HaCaT) and haemolysis assays.
Materials and Methods

Peptide synthesis
Cinnamic acid, 3,5-dimethoxy-4-hydroxycinnamic acid, 3-(4-hydroxphenylpropionic) acid, p-anisic acid and 6-maleimidocaproic acid were obtained from Sigma-Aldrich (Dorset, UK). Peptide purity was analysed via reverse-phase HPLC using an Agilent 1260 Infinity system, fitted with a Gemini C18, 250 mm × 4.6 mm column, a 2−60% acetonitrile gradient [30 min] in 0.05% TFA water at a flow rate of 1.5 mL/min. All peptides were found to have >90% purity.
Microorganisms, strains and culture conditions
Biofilm forming medical device related pathogens tested were as follows: methicillin 
Determination of MIC, minimum bactericidal (MBC)/fungicidal concentration (MFC)
Broth microdilution tests were performed according to CLS guidelines as described previously by our group in 96-well microtitre plates [6] . Peptides were dissolved in MHB and sterility ensured by passing through a 0.22µm sterile filter. Peptides were tested over the concentration range 1000-3.91µg/mL with MIC determined visually after 24 hour incubation at 37ºC. MBC/MFC were determined by inoculating Müeller-Hinton agar (MHA) plates with wells that demonstrated inhibited growth (clear wells). Plates were incubated at 37ºC for 24 hour and observed for 99.9% kill.
Planktonic kill kinetics
The ability of peptides to kill planktonic isolates were evaluated as previously outlined [7] . A concentration of four times the MIC for each peptide allowed for effective analysis of the kill kinetics of each antimicrobial. Time points selected to assess planktonic kill kinetics were 10 minutes (0.1667 hours), 1, 1.5, 2, 4, 6 and 24 hours and five replicates studied. 20µL aliquots were removed at each time point and serially diluted in universal neutraliser [7] . Viable colony counts, recorded as colony forming units per millitre (CFU/mL), were obtained by Miles and Misra technique via plating on MHA and incubating for 24 hours at 37ºC.
Minimum Biofilm Eradication Concentration (MBEC) determination
The ability of each peptide to eradicate established 24 hour single special biofilms was assessed using the Calgary Biofilm Device (MBEC Assay for Physiology & Genetics (P&G), Innovotech Inc., Alberta, Canada) by a method developed fully and previously described by our group [6] . Biofilms were challenged with each individual peptide (1000-3.91µg/mL) for 24 hours with six replicates at each concentration. After treatment a recovery plate was formed by addition of 200µL of MHB to each well of a separate 96-well microtitre plate and incubating the treated MBEC lid (containing pegs) for 24 hours. The plate was examined visually and the lowest concentration with no visual growth for each peptide was designated as the MBEC.
Biofilm kill kinetics
Biofilm eradication was evaluated over 24 hours using a Calgary Biofilm Device and a method developed previously by our group [7] . If deemed active (MBEC ≤1000µg/mL) 
Cell cytotoxicity
HaCaT cell lines (collection number: 400693) were purchased from Cell Line Services 
Haemolysis assay
Peptides were assayed for their ability to induce haemoglobin release from fresh equine erythrocytes as previously outlined [6] . Fresh defibrinated equine erythrocytes (Laboratory Supplies & Instruments Ltd., Antrim, UK) were washed three times with equal volumes of PBS and centrifuged for 15 minutes at 900g. Erythrocytes were resuspended 4% (volume/volume) in PBS and 100µL of erythrocyte suspension added to each well of a 96-well microtitre plate. Erythrocytes were exposed to doubling dilutions of peptide (1000-3.91µg/mL), incubated at 37°C for 1 hour and centrifuged at 1000g. Supernatants were transferred to a fresh 96-well microtitre plate, and haemoglobin release determined at 405 nm using a Tecan Sunrise® plate reader. Erythrocytes treated with 0.1% Triton X-100 represented positive controls (100% haemolysis) and PBS (0% haemolysis) acted as a negative control. Results are reported as the mean of six replicates.
Percentage haemolysis was calculated as follows in equation 1:
Equation 1 Statistical Analysis
Statistical analyses were carried out using GraphPad Prism 6. Rate of biofilm eradication (biofilm viable count (Log10 CFU/peg) at each time point) and planktonic rate of kill (Log10 planktonic viable counts (Log10 CFU/mL)) for each peptide was examined using a KruskallWallis test, with a Dunn's post-hoc test used to identify individual differences relative to the untreated control (PBS) for each peptide at each timepoint. These tests were also utilised for statistical analysis of tissue culture and haemolysis cytotoxicity data whereby percentage viability/haemolysis for the peptides employed were also compared to the untreated (PBS) control (100% viability/0% haemolysis). Data was shown to be non-normally distributed using the Kolmogorov and Smirnov method, therefore validating the selection of the nonparametric Kruskal−Wallis test. In all cases a probability of p <0.05 denoted significance.
Results and Discussion
For ultrashort peptide derivatives, antimicrobial activity is clearly influenced by the nature of the N-terminal substituent [6] . Activity against the selected planktonic isolates, Gram- and 250µg/mL). Carboxylic acid derivatives of cinnamon extracts were conjugated to the amino terminus to provide further bulk (increasing the lipophilic:charge ratio) and increasing antimicrobial activity.
Cinnamic acid and its structural derivatives are phenolic acids. They are highly lipophilic, possess anti-oxidant effects, act as chelators and free radical scavengers, and demonstrate inherent antimicrobial activity [8] . Examples include ethanolic extracts obtained from exotic plants, such as Onosma hispidum, which are associated with the herbal treatment of infection and burns [9] . The antimicrobial effects of traditional medicines such as the Iranian folk medicine propolis have been attributed to phenolic acids, more specifically; 3,4-dimethoxycinnamic acid [10] . Related compounds have also generated interest as potential agents against tuberculosis and its causative microorganism Mycobacterium tuberculosis.
Cinnamic acid-based derivatives have been proven to inhibit the fatty acid synthase type II system of M. tuberculosis, a process essential for the organism's survival [11] . The antibacterial activity of cinnamic acid derivative's may be due to inhibition of the bacterial cell division protein FtsZ. FtsZ is the key protein of the contractile ring that forms between at the bacterial membrane before cell division and cinnamic acid inhibits bacterial replication by prevention of its assembly [12] . Truchado et al hypothesised that honey containing hydroxy cinnamic acid (similar to 3-(4-hydroxphenyl)propionic acid) may exert its antibacterial action by inhibition of quorum sensing pathways [13] . These compounds may therefore provide benefit in preventing biofilm formation in both Gram-positive and negative bacteria via inhibition of oligopeptides and acylated homoserine lactones respectively, with potential benefits for the prevention of medical device related infection. Table 1 ).
Related lipophilic moieties provide similar antimicrobial benefits when attached to the tetrapeptide motif. 3,5-dimethoxy-4-hydroxycinnamic acid, commonly known as sinapic or sinapinic acid, demonstrate antibacterial activity against Gram-negative E.coli due to the presence of two methoxyl and one hydroxyl grouping ( Figure 1 , structure 2) [15] . Such groupings have a high affinity for bacterial proteins and specifically enzymes, with the presence of at least one phenolic hydroxyl group and a certain degree of lipophilicity shown to provide antimicrobial character [16] . Although antimicrobial activity is demonstrated for 3,5-dimethoxy-4-hydroxycinnamic-Orn-Orn-Trp-Trp-NH2 against planktonic forms of E. coli and P. aeruginosa (MIC and MBC values both 250µg/mL for each, Table 1 ) it is more selective for Gram-positive microorganisms, a pattern that correlates to all peptides tested.
The increased hydrophilicity provided by the two methoxyl and one hydroxyl grouping on the 3,5-dimethoxy-4-hydroxycinnamic is negated by the presence of the cationic peptide moiety that favours interaction and activity against Gram-positive bacteria and its membrane [17] .
Another plant extract containing a methoxy grouping that demonstrates antimicrobial action in the literature is p-anisic acid. Originating from sources such as aniseed (Pimpinella anisum), p-anisic acid alone displays mg/mL activity against resistant bacterial strains such as MRSA [18] . Conjugation to the tetrapeptide motif increases activity of the p-anisic grouping further with MIC, MBC and MBEC values at 250µg/mL against MRSA (ATCC 43300). 6-maleimidocaproic acid was selected as an alternative amino terminal moiety to the cinnamic acid derivatives. 6-maleimidocaproic acid is commonly used as a peptide probe for identifying thiol groups present within cell membranes, binding with cell membrane bound proteins with high affinity [19] . Its ability to increase interactions with microbial membrane bound proteins was hypothesised to allow the antimicrobial peptide motif to exert a greater antimicrobial action at the membrane interface. The structure of 6-maleimidocaproic acid may also provide antimicrobial activity in itself due to the presence of two highly electronegative oxygen atoms and a nitrogen supplying charge, balanced by a lipophilic hydrocarbon tail ( Figure 1 , structure 5). However in the majority of cases, the addition of a Kill kinetics were assessed against planktonic microorganisms at four times the MIC value.
The selection of an antimicrobial concentration of four times the MIC allowed for effective analysis of the kill kinetics (bactericidal). Rapid cidal action was demonstrated for all peptides with total kill of planktonic microorganisms within 10 minutes exposure (Table S2) .
These results prove a rapid bactericidal effect is achieved within minutes against planktonic forms of Gram-positive and negative bacteria and also fungi, likely due to targeting of cellular membranes [21] . The mechanism of action of these cationic peptides is mainly due to cidal not inhibitory action. The potential for resistance developing is lessened further by many antimicrobial peptides possessing similar MIC and MBC values [22] . Many of the MIC and MBC values obtained (Table 1) epidermidis to other antimicrobial peptides including human β-defensin 3, LL-37, and anionic dermcidin [23] .
Antimicrobial potency shows a marked reduction against biofilms of Gram-negative bacteria and the fungus C. tropicalis. Reduced activity against biofilm forms of Gram-negative bacteria has also been demonstrated by Chan and colleagues [24] . They observed that cationic antimicrobial peptides, over a specific hydrophobicity threshold aided by the presence of tryptophan and basic lysine residues, bound to alginate, the main exopolysaccharide matrix substance of P. aeruginosa. Binding occurred to such an extent that the hydrophilic alginate polymer behaves as an "auxiliary membrane" protecting the biofilm bacteria from the action of cationic peptides. The biofilm form of the strain of P. aeruginosa (PAO1) utilised in this study is non-mucoid and thus observations of the extracellular polymeric substances present in P. aeruginosa (PAO1) show that the main carbohydrate constituents are glucose, mannose and rhamnose not the alginic acid components mannuronate or guluronate [25] . Therefore other resistance mechanisms must exist to explain the relative large increase in MIC, MBC and MBEC values obtained in Table 1 demonstrated no significant haemolysis up to concentrations of 1000µg/ml (Figure 8 ). These cationic peptides bind preferentially to the negatively charged phospholipid bilayer of bacterial cells [6] . This is advantageous with regard to reducing toxicity in any potential therapeutic environment. The structure of human erythrocyte membranes have shown that they contain a large number of highly negatively charged sialic acid molecules present in the glycocalyx layer as glycosphingolipids and glycoproteins, projecting from the erythrocyte surface [29] . These may prove to be potential binding sites for cationic antimicrobials.
Regardless of this, binding and permeation are much more effective in bacteria than in eukaryotic glycocalyx of erythrocytes as peptides find it harder to cross the carbohydratebased barrier. The majority of non-haemolytic peptides cannot cross the membrane due to a low affinity for the zwitterionic phospholipid bilayer. Cationic antimicrobial peptide's affinity for acidic phospholipids tends to be a lot higher than for zwitterionic phospholipids as demonstrated [30] . Selectivity for biofilm forms of Gram-positive bacteria is also greater than for eukaryotic cells as demonstrated by complete eradication of biofilms occurring at µg/ml concentrations, with no significant cytotoxicity demonstrated within this range.
Conclusions
In this paper, we explored the in vitro antimicrobial properties of ultrashort cinnamon-peptide as therapeutics and their potential to be of benefit to limit the increasing spectre of antimicrobial resistance, particularly in device related infection.
